Determination of sample sizes for demonstrating efficacy of radiation countermeasures

Biometrics

Volumn 66, Issue 1, 2010, Pages 239-248

  Kodell, Ralph L ^a   Lensing, Shelly Y ^a   Landes, Reid D ^a   Kumar, K Sree ^b   Hauer Jensen, Martin ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Dose reduction factor; Logit; Power; Probit; Quantal assay; Radiation countermeasures; Radiation protection; Relative potency; Terrorism

Indexed keywords

HEALTH RISKS; INTELLIGENT SYSTEMS; MONTE CARLO METHODS; RADIATION EFFECTS; RADIATION PROTECTION; TERRORISM;

DOSE REDUCTION; DOSE REDUCTION FACTOR; LOGIT; POWER; PROBIT; QUANTAL ASSAY; RADIATION COUNTERMEASURE; REDUCTION FACTOR; RELATIVE POTENCIES; SAMPLE SIZES;

ANIMALS;

DOSE-RESPONSE RELATIONSHIP; DRUG; DRUG DEVELOPMENT; HEALTH IMPACT; IRRADIATION; LOGIT ANALYSIS; MODEL TEST; MONTE CARLO ANALYSIS; NUCLEAR POWER; RADIATION BALANCE; RESEARCH WORK; SAMPLE PREPARATION; SIZE STRUCTURE; STUDENT; TERRORISM; TOXICITY TEST;

ANIMALIA;

RADIOPROTECTIVE AGENT;

ANIMAL; COMPUTER SIMULATION; DRUG SCREENING; HUMAN; OUTCOME ASSESSMENT; PREVALENCE; PROCEDURES; RADIATION INJURIES; RADIATION PROTECTION; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

ANIMALS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RADIATION INJURIES; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 77949705416     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2009.01236.x     Document Type: Article

References (28)

1. Brown, B. W. (1966). Planning a quantal assay of potency. Biometrics 22, 322-329.
2. British Toxicology Society Working Group on Toxicity. (1984). A new approach to the classification of substances and preparations on the basis of their acute toxicity. Human Toxicology 3, 85-92.
3. Bruce, R. D. (1985). An up-and-down procedure for acute toxicity testing. Toxicological Sciences 5, 151-157.
4. Casarett, L. J. and Doull, J. (1975). Toxicology, The Basic Science of Poisons. New York: MacMillan.
5. Elashoff, J. (1996). nQuery Advisor Sample Size and Power Determination. Boston: Statistical Solutions Limited.
6. FDA (U. S. Food and Drug Administration). (1988). FDA policy statement on the LD50. Federal Register 53, Docket No. 86P-0224, 39650.
7. FDA (U. S. Food and Drug Administration). (2002). New drug and biological drug products: Evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Federal Register 67, 37988-37998.
8. Finney, D. J. (1978). Statistical Method in Biological Assay, 3rd edition. New York: Macmillan.
9. Hauer-Jensen, M., Kumar, K. S., Wang, J., Berbee, M., Fu, Q., and Boerma, M. (2008). Intestinal toxicity in radiation and combined injury: Significance, mechanisms, and countermeasures. In Global Terrorism Issues and Developments, R. A. Larche (ed), 61-100. Hauppauge, New York: Nova Science Publishers.
10. Hintze, J. L. (2005). PASS Quick Start: Power Analysis and Sample Size System. Kaysville, Utah: NCSS.
11. Hosmer, D. W. and Lemeshow, S. (2000). Applied Logistic Regression, 2nd edition. New York: Wiley.
12. Hsieh, F. (1991). SSIZE: A sample size program for clinical and epidemiologic studies. American Statistician 45, 338.
13. Hsieh, F.Y., Bloch, D. A., and Larsen,M. D. (1998). A simple method of sample size calculation for linear and logistic regression. Statistics in Medicine 17, 1623-1634.
14. Kraemer, H. C. and Paik, M. (1979). A central t approximation to the noncentral t distribution. Technometrics 21, 357-360.
15. Kumar, K. S., Ghosh, S. P., and Hauer-Jensen, M. (2009). Gammatocotrienol: Potential as a countermeasure against radiological threat. In Tocotrienols-Vitamin E Beyond Tocopherols, R. R. Watson and V. R. Preedy (eds), pp. 379-398. Boca Raton, Florida: CRC Press.
16. Mettler, F. A. and Voelz, G. L. (2002). Major radiation exposure-what to expect and how to respond. New England Journal of Medicine 346, 1554-1561.
17. Morgan, B. J. T. (1992). Analysis of Quantal Response Data. New York: Chapman and Hall.
18. OECD (Organisation for Economic Co-operation and Development). (2001). OECD Guideline for Testing of Chemicals, No. 425. Acute Oral Toxicity-the Up-and-Down Procedure. Paris: OECD.
19. Pellmar, T. C. and Rockwell, S. (2005). Priority list of research areas for radiological nuclear threat countermeasures. Radiation Research 163, 115-123.
20. R Development Core Team. (2007). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. http://www.R-project.org, accessed November 2, 2007.
21. Robinson, S., Delongeas, J. L., Donald, E, Dreher, D., Festag. M., Kervyn, S., Lampo, A., Kamil, N., Nogues, V., Ockert, D., Quinn, K., Old, S., Pickersgill, N., Somers, K., Stark, C., Stei, P., Waterson, L., and Chapman, K. (2008). A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical development. Regulatory Toxicology and Pharmacology 50, 345-352.
22. SAS. (2004). SAS/STAT 9.1 User's Guide, Volumes 4 and 5. Cary, North Carolina: SAS Institute, Inc.
23. Singh, V. K., Srinivasan, V., Seed, T. M., Jackson, W. E., Miner, V. E., and Kumar, K. S. (2005). Radioprotection by N-palmitoylated nonapeptide of human interleukin-1β. Peptides 26, 413-418.
24. Stone, H. B., Moulder, J. E., Coleman, C. N., Ang, K. K., Anscher, M. S., Barcellos-Hoff, M. H., Dynan, W. S., Fike, J. R., Grdina, D. J., Greenberger, J. S., Hauer-Jensen, M., Hill, R. P., Kolesnick, R. N., MacVittie, T. J., Marks, C., McBride, W. H., Metting, N., Pellmar, T., Purucher, M., Robbins, M. E., Schiestl, R. H., Seed, T. M., Tomaszewski, J. E., Travis, E. L., Wallner, P. E., Wolpert, M., and Zaharevitz, D. (2004). Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop. Radiation Research 162, 711-728.
25. Trevan, J. W. (1927). The error of determination of toxicity. Proceedings of the Royal Society 101B, 483-514.
26. Walum, E. (1998). Acute oral toxicity. Environmental Health Perspectives 106, 497-503.
27. Waselenko, J. K., MacVittie, T. J., Blakeley, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., Lowry, P., Armitage, J. O., and Dainiak, N. (2004). Medical management of the acute radiation syndrome: Recommendations of the strategic national stockpile radiation working group. Annals of Internal Medicine 140, 1037-1051.
28. Whittemore, A. (1981). Sample size for logistic regression with small response probability. Journal of the American Statistical Association 76, 27-32.